Literature DB >> 30999112

UCA1 promotes cell viability, proliferation and migration potential through UCA1/miR-204/CCND2 pathway in primary cystitis glandularis cells.

Xu Zhou1, Yu Cui2, Jinbo Chen2, Chao Li2, Fengmin Chen2, Xiang Chen2, Zhenyu Ou2, Xu Cheng2, Wenbiao Ren2, Huihuang Li2, Xiongbing Zu2, Nenghui Liu3.   

Abstract

Cystitis glandularis (CG) is an unusual proliferative disorder of the urinary bladder. Increasing evidences demonstrated that long non-coding RNAs (lncRNAs) play important roles in a variety of cellular progresses. However, there are rarely reports about the role and underlying molecular mechanism of lncRNAs in CG. In this study, we firstly isolated the primary cells from the tissues of CG and adjacent normal tissues, and found that UCA1 was up-regulated in the primary CG cells (pCGs). Then, we showed that knock out of UCA1 reduced the cell viability, inhibited the cell proliferation and restrained the migration potential and overexpression of UCA1 promoted that in pCGs. Furthermore, we demonstrated that UCA1 played its role via sponging of the miR-204 in pCGs. In addition, we illustrated that miR-204 exerted its function via targeting CYCLIN D2 (CCND2) 3'UTR at mRNA level in pCGs. Ultimately, we revealed the role and regulation of UCA1/miR-204/CCND2 regulatory axis in pCGs. In summary, our study, for the first time, revealed the role and underlying mechanism of an lncRNA UCA1 in CG, providing a potential biomarker and therapeutic target for human CG.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  CCND2; Cystitis glandularis; UCA1; ceRNA; miR-204

Mesh:

Substances:

Year:  2019        PMID: 30999112     DOI: 10.1016/j.biopha.2019.108872

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Long non-coding RNA UCA1 upregulates KIF20A expression to promote cell proliferation and invasion via sponging miR-204 in cervical cancer.

Authors:  Qing He; Jianzhou Meng; Shuai Liu; Qiangcheng Zeng; Qinghua Zhu; Zhenlin Wei; Yibo Shao
Journal:  Cell Cycle       Date:  2020-08-23       Impact factor: 4.534

2.  Downregulated lncRNA UCA1 acts as ceRNA to adsorb microRNA-498 to repress proliferation, invasion and epithelial mesenchymal transition of esophageal cancer cells by decreasing ZEB2 expression.

Authors:  Peng Wang; Xinfa Liu; Gaohua Han; Shengbin Dai; Qingtao Ni; Shujun Xiao; Junxing Huang
Journal:  Cell Cycle       Date:  2019-08-06       Impact factor: 4.534

3.  A comprehensive evaluation of differentially expressed mRNAs and lncRNAs in cystitis glandularis with gene ontology, KEGG pathway, and ceRNA network analysis.

Authors:  Chao Li; Jiao Hu; Peihua Liu; Qiaqia Li; Jinbo Chen; Yu Cui; Xu Zhou; Bichen Xue; Xin Zhang; Xin Gao; Xiongbing Zu
Journal:  Transl Androl Urol       Date:  2020-04

4.  Development and validation of a predictive nomogram for the risk of recurrence in patients with cystitis glandularis.

Authors:  Jiao Hu; Chao Li; Xi Guo; Huihui Zhang; Huihuang Li; Dongxu Qiu; Guanghui Gong; Peihua Liu; Wenbiao Ren; Jinbo Chen; Xiongbing Zu
Journal:  Ann Transl Med       Date:  2020-03

5.  CircTHBS1 targeting miR-211/CCND2 pathway to promote cell proliferation and migration potential in primary cystitis glandularis cells.

Authors:  Yue Ma; Zhengfei Shan; Ying Liu; Honggang Shao; Yupeng Xin; Kai He; Shichun Jiang; Yaodong Wang
Journal:  Biosci Rep       Date:  2021-08-27       Impact factor: 3.840

6.  Tumor protein P63 Regulated 1 contributes to inflammation and cell proliferation of cystitis glandularis through regulating the NF-кB/cyclooxygenase-2/prostaglandin E2 axis.

Authors:  Tao Hong; Songzhe Piao; Liangxue Sun; Yiran Tao; Mang Ke
Journal:  Bosn J Basic Med Sci       Date:  2022-02-01       Impact factor: 3.363

7.  Overexpression of PKMYT1 Facilitates Tumor Development and Is Correlated with Poor Prognosis in Clear Cell Renal Cell Carcinoma.

Authors:  Peng Chen; Ziying Zhang; Xiang Chen
Journal:  Med Sci Monit       Date:  2020-10-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.